SOLICITATION NOTICE
R -- Centralized Follow-up for the Prostate, Lung, Colorectal and Ovanian Cancer Screening Trial
- Notice Date
- 4/23/2010
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 541990
— All Other Professional, Scientific, and Technical Services
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 6120 Executive Blvd., EPS Suite 600, Rockville, Maryland, 20852
- ZIP Code
- 20852
- Solicitation Number
- N02-CN-05019-61
- Point of Contact
- Charles H Jackson, Jr., Phone: 301-435-3829
- E-Mail Address
-
cj14k@nih.gov
(cj14k@nih.gov)
- Small Business Set-Aside
- N/A
- Description
- NOTE – This synopsis follows a Sources Sought notice that was released on February 18, 2010 under Solicitation Number SS=PCPSB-05019-61. The Division of Cancer Prevention and Control, NCI approved the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial in January 1991. Contracts were awarded in September 1992. Ten Screening Centers (SCs), a Coordinating Center (CC), and a Laboratory (Lab) were competitively selected. In July 2009, the NCI approved the continuation of centralized follow-up of PLCO participants beyond the originally planned 13-year follow-up period. Currently the 10 Screening Centers are conducting the follow-up activities and the intent is to administer follow-up through a single contractor. The National Cancer Institute (NCI), Divisions of Cancer Epidemiology and Genetics (DCEG) and Cancer Prevention (DCP) is proposing to contract for services to support centralized follow-up of Prostate Lung Colorectal and Ovarian (PLCO) Cancer Screening Trial participants who have agreed to continued PLCO participation to obtain cancer diagnosis-, death- and risk factor-related data on these participants to determine if screening for the named cancers reduces deaths from these cancers. Approximately 155,000 men and women were enrolled in PLCO between 1993 and 2001. An anticipated 80,000 to 90,000 participants will be included in centralized follow-up. The NAICS code for the project is 541990. The small business size standard is $7M. The proposed acquisition will involve the following type of activities: 1) Establish a Central Data Collection Center (CDCC) for the continued, centralized follow up of PLCO participants for approximately five years, 2) Develop a mechanism to transfer data from the central data collection server to the existing PLCO Coordinating Center, 3) Prepare IRB Submissions as required, 4) Conduct Annual Study Update Administration to determine participants’ current health and identify newly diagnosed cancers, 5) Conduct Risk Factor Questionnaire Administration to enhance key exposure data, 6) Conduct Health Status Questionnaire (HSQ) Administration to assess current screening behavior in the cohort, 7) Conduct Retention Activities to keep participants engaged in the study, 8) Conduct Tracing Procedures for participants lost to follow up, 9) Conduct Medical Record Collection and Abstraction for identified cancers,10) Conduct Pathology Tissue Collection from identified cancers, 11) Collect Death Certificates from next of kin of deceased participants or from state agencies to ascertain the cause of death, 12) Provide coordination with the PLCO Sites to establish scientific and administrative liaisons with personnel from the ten original PLCO Screening Centers to facilitate clinical data collection, if needed, 13) Identify Sites that will need to submit to State Tumor Registries, 14) Establish a toll-free Call Number for PLCO Participants and 15) Establish a PLCO Website for PLCO Participants. A pre-proposal conference related to this solicitation will be held via NIH videocast on May 26, 2010 from 1:00 PM to 4:00 PM. Additional information regarding this pre-proposal conference may be found in the solicitation under Section L.1(d). Prospective offerors are expected to review the solicitation in detail and be prepared to submit questions in advance of the conference to allow the most efficient use of the allotted time. The NCI intends to award one cost-reimbursement contract with a period of performance of five years. The Government intends to have a full & open competition for this requirement in the form of a Request for Proposal (RFP). This synopsis is not an RFP; an RFP is anticipated for release on or about May 10, 2010 through Federal Business Opportunities (http://fbo.gov). Questions regarding this requirement must be submitted in writing and directed to Charles H. Jackson, Jr., Contracting Officer at cj14k@nih.gov. The reference number to be used for this announcement is RFP: N02-CN-05019-61. All correspondence must cite the reference number as provided.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/RCB/N02-CN-05019-61/listing.html)
- Record
- SN02130775-W 20100425/100423235335-28636502ea89016c8ab5fe4ea6c06614 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |